Global Synthetic Biology Market 2023 Opportunity Assessment, Growth Rate, Latest Trends And Forecast To 2032 | Major Players Are Thermo Fisher Scientific Inc, Danaher Corporation, Eurofins Scientific, Merck KGaA, Novozymes A/S

As per The Business Research Company's Synthetic Biology Opportunities And Strategies Market Report 2023, The global synthetic biology market size reached a value of nearly $10,132.4 million in 2021, having increased at a compound annual growth rate (CAGR) of 21.4% since 2016. The market is expected to grow from $10,132.4 million in 2021 to $ 33,492.2 million in 2026 at a rate of 27.0%. The global synthetic biology market size is then expected to grow at a CAGR of 16.4% from 2026 and reach $71,709.6 million in 2031.

The increase in demand for genetically modified crops due to the surging population is also driving the global synthetic biology market. GMOs are genetically modified, which means that the organism's natural DNA has been altered in a lab by artificial human interference (as opposed to intervention through crossbreeding, which used to be the only way to manipulate organisms to get desired characteristics). For example, in 2022, according to the center for food safety, currently, 94% of cotton, 94% of soybeans, and up to 92% of corn in the United States are genetically modified (GE) (cottonseed oil is often used in food products). According to estimates, up to 75% of processed items on store shelves, including soda, soup, crackers, and sauces, include ingredients that were genetically modified. Therefore, an increase in demand for genetically modified crops for supporting synthetic biology will promote the growth of the market.

View Complete Report @
https://www.thebusinessresearchcompany.com/report/synthetic-biology-market

Companies in the synthetic biology market are focusing on the development of automated solutions for nucleotide synthesis and sequencing devices and equipment used for COVID-19 testing. This will help to enhance the productivity and consistency of the whole sequencing process, along with reducing contact points for samples, consumables, and liquid handling, which improves the safety of clinical and laboratory personnel. Automation increases speed, reduces errors, and the number of tests that can be performed per day also increases. For instance, Switzerland-based healthcare company Roche's RT-PCR testing Cobas platform, which was granted Emergency Use Authorization by the FDA in March 2020, automates the testing of nasopharyngeal and oropharyngeal swab samples from patients suspected of having COVID-19. The Roche Cobas 8800, which is nearly fully automated, can test human samples about 10 times faster.

The top opportunities in the synthetic biology market segmented by material will arise in the bioinformatics segment, which will gain $6,323.2 million of global annual sales by 2026. The top opportunities in segment by application will arise in the pharmaceuticals segment, which will gain $11,105.3 million of global annual sales by 2026. The top opportunities in segment by type will arise in the oligonucleotides, which will gain $9,568.3 million of global annual sales by 2026. The synthetic biology market size will gain the most in the USA at $7,045.5 million. .

Synthetic Biology Market Segmentation:
The Synthetic Biology Market is segmented by technology, by application and by product type

By Technology -
The synthetic biology market is segmented by technology into
a) Nucleotide Synthesis And Sequencing
b) Bioinformatics
c) Microfluidics
d) Genetic Engineering

By Application -
The synthetic biology market is segmented by application into
a) Pharmaceuticals And Diagnostics
b) Chemicals
c) Biofuels
d) Bioplastics
e) Other Application

By Product Type -
The synthetic biology market is segmented by product type into
a) Oligonucleotides
b) Enzymes
c) Cloning And Assembly Kits
d) Xeno-Nucleic Acids (XNA)
e) Chassis Organism

Major players in the Synthetic Biology Market include Thermo Fisher Scientific Inc, Danaher Corporation, Eurofins Scientific, Merck KGaA, Novozymes A/S.

The regions covered in the global Synthetic Biology Market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Download FREE SAMPLE Report - https://www.thebusinessresearchcompany.com/sample_request?id=5366&type=smp

The latest report from The Business Research Company, 'Global Synthetic Biology Opportunities And Strategies Market Report - Forecast To 2032,' provides a comprehensive global perspective with data and statistics from 60+ geographies, analyzing 7000+ market segments. The regional and country breakdowns section offers insights into each geography's market analysis, size, historic and forecast growth, and key strategies for industry competitiveness.

Synthetic Biology Market Report Table Of Content
1.Executive Summary
2.Table of Contents
3.List of Figures
4.List of Tables
5.Report Structure
……
18. Competitive Landscape And Company Profiles
19. Company Profiles
20. Key Mergers and Acquisitions
21. Global Synthetic Biology Market Opportunities And Strategies
22.Synthetic Biology Market, Conclusions And Recommendations

PURCHASE the report @
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5366

Get to know us better:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/

This release was published on openPR.